Error: Could not add to watchlist. X

AXA Framlington Biotech Fund

+ Watchlist
FRABIOI:LN
182.00
GBp
2.30
1.25%
As of 00:59:30 ET on 07/30/2015.
Fund Type
Unit Trust
52Wk Range
110.08 - 193.50
1 Yr Return
59.81%
YTD Return
22.23%
Previous Close
184.30
52Wk Range
110.08 - 193.50
1 Yr Return
59.81%
YTD Return
22.23%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/30/2015)
182
Total Assets (m GBP) (on 07/30/2015)
805.395
Inception Date
11/26/2001
Last Dividend (on 03/02/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
5.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
1.95%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 924.16 k 68.81 m 9.40
Celgene Corp 875.22 k 64.42 m 8.80
Biogen Inc 242.22 k 62.22 m 8.50
Amgen Inc 517.35 k 50.51 m 6.90
Alexion Pharmaceuticals Inc 362.95 k 41.72 m 5.70
Illumina Inc 263.57 k 36.60 m 5.00
Vertex Pharmaceuticals Inc 391.52 k 30.74 m 4.20
Regeneron Pharmaceuticals Inc 92.51 k 30.01 m 4.10
BioMarin Pharmaceutical Inc 311.37 k 27.08 m 3.70
Incyte Corp 364.51 k 24.16 m 3.30
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
ADDRESS
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
PHONE
44-207-374-4100